Aktiespot

Guided Therapeutics, Inc. aksje

GTHP

$0.2040-0.0250 (-10.92%)
Laster graf...
Guided Therapeutics, Inc. logo

Guided Therapeutics, Inc.

Åpning0.2000
Høy0.2290
Lav0.2000
Volum2.6k
P/EN/A
Markedsverdi19.69M
52-ukers høy0.5400
52-ukers lav0.1230
Gj.sn. volum17.34k
UtbytteN/A
Beta0.79
EPS-0.0400

Om Guided Therapeutics, Inc. aksje

Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.

Selskapsinformasjon

Børs: OTC Markets OTCQB (OQB)
Sektor: Sundhed
Industri: Medicinsk udstyr
Adresse:
5835 Peachtree Corners East
30092 Peachtree Corners, United States
Telefon: + 770 242 8723

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: